BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18325046)

  • 1. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.
    Yoshinaga K; Ito K; Moriya T; Nagase S; Takano T; Niikura H; Yaegashi N; Sato Y
    Cancer Sci; 2008 May; 99(5):914-9. PubMed ID: 18325046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas.
    Yoshinaga K; Ito K; Moriya T; Nagase S; Takano T; Niikura H; Sasano H; Yaegashi N; Sato Y
    Cancer Sci; 2011 Feb; 102(2):446-51. PubMed ID: 21175993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
    Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
    Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
    Wakusawa R; Abe T; Sato H; Yoshida M; Kunikata H; Sato Y; Nishida K
    Am J Ophthalmol; 2008 Aug; 146(2):235-243. PubMed ID: 18486097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer.
    Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Tomala B; Halski T; Leśniak E; Januszyk K; Brus R; Kiełbasiński R; Boroń D
    Curr Pharm Biotechnol; 2019; 20(11):955-963. PubMed ID: 31322068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer.
    Dobrzycka B; Terlikowski SJ; Kwiatkowski M; Garbowicz M; Kinalski M; Chyczewski L
    Ginekol Pol; 2010 Jun; 81(6):422-5. PubMed ID: 20695190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cytokine-induced expression of vasohibin-1 by rheumatoid synovial fibroblasts.
    Miyake K; Nishida K; Kadota Y; Yamasaki H; Nasu T; Saitou D; Tanabe K; Sonoda H; Sato Y; Maeshima Y; Makino H
    Acta Med Okayama; 2009 Dec; 63(6):349-58. PubMed ID: 20035291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF and its receptors (flt-1 and KDR/flk-1) as prognostic indicators in endometrial carcinoma.
    Talvensaari-Mattila A; Soini Y; Santala M
    Tumour Biol; 2005; 26(2):81-7. PubMed ID: 15867479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
    Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
    Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
    Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
    Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle.
    Meduri G; Bausero P; Perrot-Applanat M
    Biol Reprod; 2000 Feb; 62(2):439-47. PubMed ID: 10642585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study on VEGF expression in endometrial carcinoma--comparison with p53 expression, angiogenesis, and tumor histologic grade.
    Fujisawa T; Watanabe J; Akaboshi M; Ohno E; Kuramoto H
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):668-74. PubMed ID: 11710596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.
    Yokoyama Y; Charnock-Jones DS; Licence D; Yanaihara A; Hastings JM; Holland CM; Emoto M; Sakamoto A; Sakamoto T; Maruyama H; Sato S; Mizunuma H; Smith SK
    Clin Cancer Res; 2003 Apr; 9(4):1361-9. PubMed ID: 12684405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis.
    Hosaka T; Kimura H; Heishi T; Suzuki Y; Miyashita H; Ohta H; Sonoda H; Moriya T; Suzuki S; Kondo T; Sato Y
    Am J Pathol; 2009 Jul; 175(1):430-9. PubMed ID: 19498005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance.
    Kato N; Watanabe J; Jobo T; Nishimura Y; Fujisawa T; Kamata Y; Kuramoto H
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):222-6. PubMed ID: 12684894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer.
    Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Halski T; Januszyk P; Kuś-Kierach A; Adwent I; Dąbruś D; Kiełbasiński K; Boroń D
    Curr Pharm Biotechnol; 2019; 20(12):1004-1010. PubMed ID: 31333122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis.
    Watanabe K; Hasegawa Y; Yamashita H; Shimizu K; Ding Y; Abe M; Ohta H; Imagawa K; Hojo K; Maki H; Sonoda H; Sato Y
    J Clin Invest; 2004 Oct; 114(7):898-907. PubMed ID: 15467828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma--the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF.
    Saito M; Watanabe J; Fujisawa T; Kamata Y; Nishimura Y; Arai T; Miyamoto T; Obokata A; Kuramoto H
    Eur J Gynaecol Oncol; 2006; 27(2):129-34. PubMed ID: 16620053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.